Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-01-29 @ 5:40 AM
Study NCT ID:
NCT01861002
Status:
COMPLETED
Last Update Posted:
2021-06-09
First Post:
2013-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2014-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-21
First Submit QC Date:
None
Study First Post Date:
2013-05-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-03
Results First Submit QC Date:
None
Results First Post Date:
2021-04-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-14
Last Update Post Date:
2021-06-09
Last Update Post Date Type:
ACTUAL